This topic contains a solution. Click here to go to the answer

Author Question: The reason for including a placebo group in a drug study is to control for: a. experimenter bias. ... (Read 183 times)

Metfan725

  • Hero Member
  • *****
  • Posts: 552
The reason for including a placebo group in a drug study is to control for:
 
  a. experimenter bias.
  b. physiological effects of the drug.
  c. participants' expectations of change.
  d. the experimenter being blind.

Question 2

To control for the Hawthorne effect, you need:
 
  a. more than one observer.
  b. a control group that is not given special attention.
  c. a control group that is given special treatment but does not get the experimental treatment.
  d. a placebo group.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

stanleka1

  • Sr. Member
  • ****
  • Posts: 325
Answer to Question 1

C

Answer to Question 2

C




Metfan725

  • Member
  • Posts: 552
Reply 2 on: Jun 20, 2018
Gracias!


lkanara2

  • Member
  • Posts: 329
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

Did you know?

The eye muscles are the most active muscles in the whole body. The external muscles that move the eyes are the strongest muscles in the human body for the job they have to do. They are 100 times more powerful than they need to be.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

Certain chemicals, after ingestion, can be converted by the body into cyanide. Most of these chemicals have been removed from the market, but some old nail polish remover, solvents, and plastics manufacturing solutions can contain these substances.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library